Weight-loss medicines such as Ozempic might raise a person’s likelihood of developing conditions including arthritis Risk assessment The study focused

o understand how GLP-1 agonists work, it helps to understand how the naturally occurring GLP-1 hormone works. GLP-1 is a

Healthcare providers prescribe GLP-1 agonists for two conditions: Type 2 diabetes and Weight Loss.

The FDA currently approves the use of semaglutide and high-dose liraglutide to help treat obesity. This is because these GLP-1

Your healthcare provider will tell you when and how often to take your medication (usually injections). Be sure to follow

Other than lowering blood sugar levels and reducing weight, studies show that GLP-1 agonists may have other potential benefits, like:

The most common side effects of GLP-1 agonists include: Loss of appetite. Nausea. Vomiting. Diarrhea. These side effects are more

GLP-1 agonists are generally safe. But there are a few risks to consider, including: Allergic reactions. Use during pregnancy. Low

There’s a low risk of mild low blood sugar (hypoglycemia) episodes if you take a GLP-1 agonist. It can become

GLP-1 agonists aren’t safe to take during pregnancy. Animal studies show that these medications cause developmental abnormalities in the fetus.

Medications are often used off label when they are found to have properties or effects that could potentially benefit a

GLP-1 is an incretin hormone that is released from the distal ileum in the small intestine and the colon within

Originally developed to improve glycaemic control in patients with type 2 diabetes, GLP-1 receptor agonists have emerged as promising agents

Along with helping to control blood sugar and boosting weight loss, GLP-1 agonists and SGLT-2 inhibitors seem to have other

Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with fewer side

Researchers are currently studying the safety and effectiveness of GLP-1 agonists for people with Type 1 diabetes (T1D). So far,

ABSTRACT: Myocardial infarction (MI) continues to be a leading cause of death in the United States. Improvements in the diagnosis

ABSTRACT: Telehealth has gained significant traction in recent years, enabling healthcare providers, including pharmacists, to enhance continuity of care. Findings

ABSTRACT: Cardiovascular disease (CVD) is the leading cause of death globally, with costs expected to increase drastically over the next

Trouble Digesting Sugar in Milk Lactose, a natural sugar found in milk and products made from milk, is digested in